Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial
Year: 2021
Type: article
Study design: Study Protocol
Source: American Heart Journal
Institutions: University of Florida Health, University of Florida, Cedars-Sinai Smidt Heart Institute, VA Boston Healthcare System, VA Palo Alto Health Care System, Stanford University, University of Virginia Health System, University of Virginia, Saint Luke's Hospital, University of Missouri–Kansas City, MedStar Heart & Vascular Institute, MedStar Health Research Institute, Uniformed Services University of the Health Sciences, Saint Louis University, Emory University, The Lundquist Institute, Harbor–UCLA Medical Center, Cedars-Sinai Medical Center
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Keywords: non-obstructive coronary artery disease, major adverse cardiac events, intensive medical therapy, high-intensity statins, ACE inhibitors, angiotensin receptor blockers, usual care, quality of life, health care utilization, angina pectoris, cardiovascular mortality, return to work, home medication delivery, biorepository
Open Access status: bronze
Funders: U.S. Department of Defense, Boehringer Ingelheim, Gustavus and Louise Pfeiffer Research Foundation, Amgen, AstraZeneca, Merck, Sanofi, Medtronic, Brigham and Women's Hospital, Gilead Sciences, Patient-Centered Outcomes Research Institute, University of Florida, CSL Behring, East Carolina University, Society for Women’s Health Research, Ladies Hospital Aid Society, Cedars-Sinai Medical Center, Adelson Family Foundation, Qmed, Cytori Therapeutics, Verily Life Sciences, Daiichi-Sankyo, National Institutes of Health, GE Healthcare, Department of Medicine, Georgetown University, National Institute on Aging, National Heart, Lung, and Blood Institute, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: G1134269671, G1313999278, G1438650436, Behavioral Medicine and Cardiovascular Research Training, G2620772713, G276921238, UCLA Clinical and Translational Science Institute, G430456586, Cardiovascular Events in Women's Ischemia Syndrome Evaluation, Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction, UFRCC for Cardiovascular Cell Therapy Research Network, General Clinical Research Center, Cardiac Autonomic Function in Women, G950221744
OpenAlex ID: W3137987119
